Related Experiment Video
Updated: Apr 5, 2026

The bm12 Inducible Model of Systemic Lupus Erythematosus SLE in C57BL/6 Mice
Published on: November 1, 2015
Systemic lupus erythematosus: an update on treat-to-target
Amy Lynn Roberts1, Denise Rizzolo
1Amy Lynn Roberts practices at the Sisselman Medical Group in Massapequa, N.Y., and is a recent graduate of the Pace Completion Program in New York City. Denise Rizzolo is an associate professor in the PA program at Seton Hall University in South Orange, N.J., an assistant clinical professor in the Pace completion program in New York City, and practices urgent care in Springfield, N.J. The authors have disclosed no potential conflicts of interest, financial or otherwise.
Abstract:
Systemic lupus erythematosus involves many organ systems, and its vague and multisystem manifestations make early diagnosis and treatment difficult. However, early diagnosis and treatment offer the best chance of reducing end-organ damage and achieving remission. This article describes a new strategy called treat-to-target that may help patients achieve remission.
More Related Videos
09:43Analyses of Proteinuria, Renal Infiltration of Leukocytes, and Renal Deposition of Proteins in Lupus-prone MRL/lpr Mice
Published on: June 8, 2022
09:38Determining Immune System Suppression versus CNS Protection for Pharmacological Interventions in Autoimmune Demyelination
Published on: September 12, 2016
Related Concept Videos
Nephrotic Syndrome II : Assessment and Medical Management
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
Autoimmune Disorders
Concept and Mechanism of Autoimmune Diseases
The immune...
Therapeutic Drug Monitoring: Affecting Factors
Rheumatic Heart Disease III: Medical Management